BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Money on the Move: Pfizer Backs Mystery Company, Teva/AbbVie Settle Opioid Suits

  Gossamer Bio sold shares of its common stock to pave its runway through mid-2024 while Teva and AbbVie reach deals in opioid settlements.

  July 13, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Drug Development

  Study: Hyperbaric Oxygen Therapy may Improve Cognitive Function in Long COVID

  Aviv Clinics reported data from a study that suggests hyperbaric oxygen therapy may alleviate long COVID symptoms, particularly those associated with cognition.

  July 13, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Global Roundup: Kyowa Kirin Drops Parkinson’s Candidate Despite Promising Phase II Data

  Kyowa Kirin announced it is dropping its Parkinson’s disease candidate, KW-6356, a follow-up to Nourianz, despite promising Phase II data that showed the drug is “potentially effective.”

  July 13, 2022

   · 

  6 min read

   · 

  Alex Keown
• 

  Drug Development

  Novartis/BeiGene Alliance Making an Impact in Esophageal Cancer

  At the end of June, Novartis announced the latest data readouts in a long string of successes for tislelizumab. BioSpace spoke with Ken Kato, an investigator on the most recent RATIONALE 306 trial.

  July 13, 2022

   · 

  5 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  Novel Peptide Could Create Pathway Against Insulin Resistance in Type 2 Diabetes

  A multinational research collaboration has developed a new peptide dubbed “PATAS”, which appears to fix the metabolic abnormalities leading to type 2 diabetes (T2D).

  July 13, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Merck-Orion Deal to Accelerate Therapy for Advanced Prostate Cancer

  The agreement with Merck brings $290 million upfront to Orion to access the latter’s investigational candidate, ODM-208, for mCPRC and other related drugs.

  July 13, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  FDA

  Novavax Stumbles Again After COVID-19 Vaccine Hit with EMA Warning - UPDATED

  The FDA granted Novavax’s COVID-19 vaccine Emergency Use Authorization after a lengthy and obstacle-riddled journey. It is authorized as a two-dose primary series for adults 18 years and older.

  July 13, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  Amazon Forays into Life Sciences with Fred-Hutch Partnered Cancer Vaccine

  In what seems like an unlikely collaboration, Seattle-based Fred Hutchinson Cancer Center (Fred Hutch) is partnering with Amazon to develop cancer vaccines.

  July 13, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  NYU Surgeons Successfully Implant Two Pig Hearts into Brain-Dead Patients

  Physicians at New York University have successfully implanted pig hearts into the bodies of patients that were living but no longer showed neural function, a process called xenotransplantation.

  July 13, 2022

   · 

  3 min read

   · 

  Jazmine Colatriano M.S.
• 

  Drug Development

  Amgen Expands Lumakras into Lung Cancer, Hints at Positive Data Coming Soon

  Early data from Amgen’s ongoing trial on Lumakras for non-small cell lung cancer hinted at positive results from what could be a transformative combination of drugs versus cancer.

  July 13, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN